Highly toxic HIV variants have existed in Europe for decades

Original author: giorgia Guglielmi

The HIV variant is more severe and infectious, but the drug is still effective.

Researchers found that a highly infectious and destructive variant of HIV has been circulating in the Netherlands for decades.

The analysis of more than 100 infected people shows that this variant will increase the number of virus particles in human blood, thus increasing the possibility of virus transmission. The mutant also seems to result in a decrease in CD4 T cells (an immune cell), so that the infected strain of the mutant will face the risk of developing AIDS (AIDS) faster than those infected with other HIV variants.

The emergence of highly toxic HIV is “the reason to be vigilant”, but this is not a public health crisis. Joel Wertheim, an evolutionary biologist and molecular epidemiologist at the University of California, San Diego, said the mutations found in the new mutant did not lead to resistance to existing HIV drugs. “All the means we have should still be effective,” he said

This variant will increase the number of HIV virus particles in the blood of infected people. Source: cavallini James / bsip / science Photo Library

The discovery, published in the journal Science on February 3, reminds us that viruses do not always evolve into low virulence over time. It has been reported that the Omicron variant infected with sars-cov-2 often causes mild covid-19 symptoms, which fuels the idea that the virus is becoming less deadly. “This is not the case,” said Emma hodcroft, a molecular epidemiologist at the University of Bern Although there are many differences between HIV and sars-cov-2, “sars-cov-2 does not necessarily become milder.” Hodcroft said.

Rapidly spreading mutant

HIV is one of the fastest mutating viruses studied so far. Variants of the virus vary from person to person, sometimes even in the same person. Previous studies have documented changes in the overall toxicity of HIV, but these changes are usually the result of different mutations in many strains. Wertheim said the study, published in science, is a clear example of how several mutations in a single HIV variant lead to changes in toxicity.

Compared with people infected with other HIV variants, the viral load in the blood of people infected with the new variant is 5.5 times, while CD4 T cells are reduced twice as fast. CD4 T cells help coordinate the response of the human immune system to infection, and their rapid decline is a sign that HIV has damaged the immune system.

The researchers estimate that if no treatment is carried out, people infected with the variant will develop AIDS within 2-3 years after diagnosis, while those infected with other HIV variants will have 6-7 years of illness.

Researchers used genome sequences to track the evolutionary relationship between HIV variants to determine the speed of virus transmission. Chris wymant, an evolutionary epidemiologist at the University of Oxford in the UK and the lead author of the study, said that people infected with the newly discovered HIV variant shared the relevant version of the virus, indicating that the variant spread rapidly from person to person.

Wymand et al estimated that this variant appeared in the Netherlands in the 1990s and spread rapidly in the early 21st century. Wymant said that the transmission of the mutant has been declining since around 2010, which may be the result of the efforts of the Netherlands to curb the spread of HIV. Two and one patients have been found in other countries, such as Switzerland and Belgium, respectively, but so far, no cases have been found further away.

“We are not overly concerned about this new variant,” said Meg Doherty, director of the World Health Organization’s global HIV, hepatitis and sexually transmitted infections program But she added that the team’s findings underscore the need for pandemic preparedness and monitoring to identify, describe and respond to new variants of pathogens.

Salim Abdool Karim, director of the AIDS project research center in South Africa, said the study highlighted the importance of extensive HIV testing and treatment services. “The key is to quickly identify infected people and start treatment early, because even for this variant, the treatment effect is very good,” he said

reference:

1.Wymant, C。 et al。 Science 375 , 540–545 (2022)。

The original text was published in the news section of nature on February 3, 2022 under the title of highly viral HIV variant found circulating in Europe

© nature

doi: 10.1038/d41586-022-00317-x